Before I start out with today’s “Idea of the Month” article I should note that I’ve had a lot of folks asking about the new “teaser” language coming from Dan Ferris for his Extreme Value newsletter — so let me quickly jump on that before I share this month’s stock idea, since it’s a stock […]
Articles
- Most Relevant
- Most Recent
Before I start out with today’s “Idea of the Month” article I should note that I’ve had a lot of folks asking about the new “teaser” language coming from Dan Ferris for his Extreme Value newsletter — so let me quickly jump on that before I share this month’s stock idea, since it’s a stock […]
This month I want to take a look at a stock I’ve mentioned in the past, but have not yet personally bought. But first, I thought I’d call your attention to another wave of negativity that could be hitting Seadrill (SDRL) shares — Elliot Gue, who was one of the first newsletter folks to call […]
I spent the day on Tuesday at the Delivering Alpha conference, which is hosted by CNBC and Institutional Investor — it’s not the kind of confab that includes “secret” or special ideas that you can’t hear about elsewhere (it’s hosted by CNBC, after all, and they broadcast from the conference all day), but it’s an […]
Crocker is a comanager at the Metropolitan Capital hedge fund. His big question is figuring out Groupe Fnac — European retailer and ticketing business (the “Ticketmaster of France). It’s priced as if disaster is around the corner, and it has a huge cash balance. Stores are mainly in France, Spain and Portugal, a few others. […]
Here’s what I’m trying to avoid: Predicting the direction of the markets because of my deep understanding of US-China trade dynamics. Every time I read an article that asserts “China trade deal more likely because of Bolton firing” or something like that, I throw up in my mouth a little bit. The market is way […]
Lots to discuss this week, mostly because several Real Money Portfolio companies reported earnings… and because I added money to two positions this week, and brought a new company into the portfolio. Enjoy! Shopify (SHOP) had reasonable earnings when they came out, but “reasonable” isn’t enough for a high-growth momentum stock that’s trading at almost […]
This one is from Chris DeHaemer at Taipan’s Red Zone profits, and it looks like it circulated pretty heavily on Friday and over the weekend. It’s for a company that uses momentum, in Dehaemer’s description, to store electrical energy, and essentially runs a big “momentum battery” that they use to buy up electricity at low […]
The Winklevoss twins came to talk to talk about Bitcoin. Which is definitely the least typical presentation I’ve seen at the Value Investing Congress — these are my notes from the talk. Bitcoin is a math-based asset created over a decentralized peer to peer network. They are hoping to convince us that Bitcoin will be […]
Before I start out with today’s “Idea of the Month” article I should note that I’ve had a lot of folks asking about the new “teaser” language coming from Dan Ferris for his Extreme Value newsletter — so let me quickly jump on that before I share this month’s stock idea, since it’s a stock […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
This time around I thought I’d get into some more detail for you on a stock I’ve written about before, and which I own personally — but I think it’s underappreciated given its potential for inflation protection and dividend growth. April’s Idea of the Month is shares of Retail Opportunity Investments Corp (ROIC). That ROIC […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
Storage of Electricity – #Batteries & BIG imageThis discussion provides the current and future of of Li, G, NAM; H2O and more… After Fukushima REBECCA JOHNSON 24 March 2011 https://www.opendemocracy.net/5050/rebecca-johnson/after-fukushima LONG TSX-V: GGG $0.25 OTCQB: $GPHBF $0.19, July 28, 2016 Graphene 3D Lab Introduces New Type of Single Layer Graphene Material: http://www.graphene3dlab.com/s/news.asp?ReportID=757543&_Type=News&_Title=Graphene-3D-Lab-Introduces-New-Type-of-Single-Layer-Graphene-Material $GLFN – http://galenfeha.com/ and #Gummune … Author: arch1 Comment: http://www.stockgumshoe.com/2016/03/microblog-club-house-for-the-discussion-of-religion-politics-and-other-unmentionables-volume-5/comment-page-17/#comment-4886050 […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] It could be the premise of a tawdry unrated movie that teenage boys sneak glimpses of on Netflix when they’re home alone. […]
“NOTE: The following presentation is based on information obtained from a closed-door meeting at the New York Stock Exchange. It contains details of the exact timeline when the next stock market crash is set to occur.” That’s the intro to the latest pitch for Steve Sjuggerud’s True Wealth — so yes, it starts out with […]
Louis Navellier is out with another of his “only a few hours left” promos to drum up new subscribes for his Ultimate Growth newsletter — he says he’s seeing huge opportunities in “AAA Rated” China growth stocks… … and in order to convince you to subscribe, he’s dropping some hints to whet your appetite for […]
This article originally appeared on January 28, 2015, when the ad was newly released — the same ad, without any major revisions that we noticed, is being distributed widely again and generating questions, so we make this piece available again. The stock teased is at roughly the same price now as it was on January […]
“I firmly believe that if the whole materia medica could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.” — Oliver Wendell Holmes, M. D., Professor of Medicine , Harvard “With all his conscience and one eye askew, So false he […]
[ed. note: Michael Jorrin, who I like to call “Doc Gumshoe,” is a medical writer (not a doctor) who shares his thoughts with our readers a couple times a month. He does not generally cover investing topics, but I find his discussions of broader health issues interesting and useful. Enjoy!] Doc Gumshoe would not be […]
Just returning from vacation, and I don’t have anything new for you just yet… but I see that the questions have been piling up about Frank Curzio’s new newsletter and the $1 gold stock he’s been touting as they drum up new subscribers. And, thankfully, that’s one I already took a quick look at — […]
[ed note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though, he mentions a couple publicly traded companies). His words and opinions are his own.] The […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] It could be the premise of a tawdry unrated movie that teenage boys sneak glimpses of on Netflix when they’re home alone. […]
We see pitches about the “end of money” all the time — across the spectrum from the goofy spiel for “loyalty points” being the next Bitcoin, to actually trading in Bitcoin, to the more popular “end of America” pitch about the dollar dying and the need to have old silver coins and gold in your […]
“HATED by the city… “DISLIKED by many of his own shareholders… “IGNORED by investors who only read the tabloid headlines… “This Controversial Retail Tycoon is About to Make a Daring E-commerce Play That’s Set to Take Many People By Surprise….” That’s the intro to the teaser pitch from the Motley Fool for their Share Advisor […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] His tidily rhyming names perhaps destined him for fame. While Jack Kerouac’s work and popularity were before my time, his cultural and literary restlessness assure him […]
I like Frank Curzio’s podcast (now called Wall Street Unplugged), and I generally find his way of thinking interesting, so after he was laid off by Porter Stansberry I was half hoping he’d go off on his own and build his own newsletter business from scratch (he edited Phase 1 Investor and Small Cap Specialist […]
Has anyone tried this? A search on Gumshoe turned up nothing, but I saw articles on Motley Fool’s site as far back as 2012, pushing this. It enables you to choose your own stocks to create what is like a self-tailored ETF – you can include up to 30 stocks (and ETFs), for a single […]
[Ed. Note: Dr. KSS writes about medicine and biotech for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] Conclusion of a Series on Pain [This column is dedicated to recovery from a recent cancer diagnosis of a stuff-of-legend friend whose life I cherish. She recently […]
This schedule shall be maintained by any IRR as a(n) event(s) occur(s) in the following format: $XYZ, Link/source,. Calculated columns/cells (TBD) may include: SP, %age SP change, Volume, MC, etc.; brief summary/comment including original comment(s)/thread(s)s/post#(s) . 125-150 characters (max), author. Schedule to exist on stockgumshoe.com/microblog utilizing google drive. This spreadsheet greatly reduce the biotech posts […]
Hi Doc, There is a teaser which talks about 3 hot companies working on pain relieving which can provide huge gains apparently. It mentions about an Arizona and Vancouver-based companies .. http://www.angelnexus.com/o/web/68345/ Google search for delta-9 gave the following companies which are doing phase3 clinical trials .. InMed Pharmaceuticals http://investorshub.advfn.com/InMed-Pharmaceuticals-Inc-IMLFF-28415/ http://www.marketwatch.com/story/inmed-pharma-proprietary-platform-growing-pipeline-low-valuation-2014-10-29 GW Pharma and Insys […]
I get asked “how do I start investing” questions quite frequently, and also questions about what kinds of online (or other) tools I use to research stocks — so I thought I’d start the discussion about this by sharing a few of my favorite things. First, if you have never invested before and don’t think […]
This thread isnt really a thread at all; although you are welcome to suggest additional rules of engagement. Its aim is to outline what is generally expected of everyone who follows/participates in the main Bio threads, and to inform you where other related specialist threads are lurking. The aim is to avoid the chaos of […]
We’re closing up shop early today for Veteran’s Day, and in the spirit of the holiday we’re running a membership special today. Stock Gumshoe will donate 50% of all membership revenue today and tomorrow to Homes for our Troops, an excellent charitable organization that builds specially adapted homes for severely disabled veterans — so for […]
A friend of mine shares his True Wealth Systems newsletter (Stansberry). Without divulging the entire content (the subject of a previous post from Travis with which I agree), they basically recommend PNC and BAC TARP warrants. I know Travis previously recommended PNC’s. I notice that the newsletter bases its recommendation on a P/B value ranging […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own.] Careful analysis of Ebola sequences in infected Africans confirms this: the entire present Ebola outbreak emerged as a consequence of one boy in Meliandoua, in eastern Guinea, eating a […]
I got this in an email, the stock looks strong, what do you think? Please ask Dr. KSS. See the first link. After an exhaustive search I found the ultimate Ebola play and one that will actually make a difference in containing this dreaded disease. When the head of the FDA comes down to your […]